Cytodyn Inc (CYDY)

[justdafactss]

LAUGHING- 4 hrs ago---

“We are guided by the WHO advisory on Ivermectin but this is not to prevent us from holding our own clinical trial,” he maintained.

Meanwhile, Albay Rep. Joey Salceda, chairman of the House committee on ways and means, has filed a bill in the House of Representatives encouraging the use of generic medicines or “biosimilar alternatives” to help indigent patients get greater access to cheaper medicines, particularly for COVID-19.

Salceda’s House Bill 9261 (Biosimilars Bill) seeks to open the market to “competitors’ versions of branded drugs” that are cheaper and affordable to indigent patients.

“Biosimilars are basically drugs that are made of the same chemicals and have the same effects as branded expensive drugs. They usually enter the market at a discount, which offers patients and the health care system the potential for savings,” he said.

“Part of what makes branded drugs expensive is that the consumer is paying for the brand. Health care is a matter of life or death, not a matter of one brand being ‘better,’ especially if the chemical composition is practically the same as cheaper drugs,” Salceda explained.

“The people are desperate for cheaper medicine. That’s why you see this hysteria over unsubstantiated cures for COVID-19. That is not good for the people. We still need proven drugs,” he said.
https://www.msn.com/en-ph/news/national/fda-allows-2-more-hospitals-to-use-ivermectin/ar-BB1g6Tdb?ocid=uxbndlbing

Proven drugs = NOT leronlimab.